Arca Biopharma | ABIO - Debt


Arca Biopharma reported $0 in Debt for its fiscal quarter ending in March of 2025.





Debt Change Date
Alterity Therapeutics Limited AUD 210.39K 120.67K Jun/2023
Amgen USD 57.32B 2.72B Mar/2026
Arca Biopharma USD 0 0 Mar/2025
Biogen USD 8.09B 1.53B Jun/2026
Brainstorm Cell Therapeutics USD 1.2M 1.2M Mar/2025
Bristol-Myers Squibb USD 46.43B 711M Mar/2026
Capricor Therapeutics USD 3.38M 0 Mar/2025
Cipla INR 6.14B 1.76B Mar/2026
Clal Biotechnology ILS 35.76M 28.27M Dec/2023
Compugen USD 2.93M 14K Mar/2026
CSL USD 11.96B 219M Dec/2024
Cytokinetics USD 1.29B 4.48M Mar/2026
Daiichi Sankyo JPY 300.48B 99.34B Mar/2026
Gilead Sciences USD 22.17B 2.76B Mar/2026
GlaxoSmithKline GBP 19.06B 1.34B Mar/2026
Grifols EUR 9.23B 626.05M Dec/2024
Laboratory Of America USD 7.24B 714.6M Mar/2026
Myriad Genetics USD 59.3M 19.7M Mar/2025
Otsuka Holdings JPY 227.98B 16.47B Dec/2025
Pfizer USD 63.19B 536M Jun/2026
United Therapeutics USD 200M 100M Mar/2025